Latest News about MRK
Recent news which mentions MRK
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment
May 13, 2024
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
Tags
AMGN
GPCR
NYSE:LLY,NYSE:NVO,NASDAQ:AMGN,NYSE:PFE,NASDAQ:VKTX,NASDAQ:GPCR,NASDAQ:ALT,NASDAQ:AZN,NYSE:MRK
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy
May 03, 2024
From Benzinga
From Benzinga
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
May 02, 2024
From Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
From Benzinga
From Benzinga
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
April 25, 2024
From Benzinga
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
April 25, 2024
From Benzinga
Tickers
MRK
From InvestorPlace
Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
April 25, 2024
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
Understanding Merck & Co's Position In Pharmaceuticals Industry Compared To Competitors
April 23, 2024
From Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
From Benzinga
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
April 17, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
